Has drug price reform already stalled? How far has tech come in medicine? And should there be an app for that?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Lev Facher joins us to explain how the latest twist in Congress could imperil a bipartisan push to lower drug costs. Then, Baylor medical ethicist Stephanie Morain stops by to explain why a new crop of apps to match cancer patients with clinical trials comes with some serious concerns. Finally, STAT’s Casey Ross dials in to talk about how the giants of tech are making inroads in health and medicine.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy